This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ clonixin lysinate,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Analgesic Effect: Clonixin lysinate is primarily used to relieve pain of mild to moderate intensity. It exerts its analgesic effects by inhibiting the synthesis of prostaglandins, which are substances involved in the mediation of pain and inflammation. By reducing prostaglandin levels, clonixin lysinate helps alleviate pain associated with conditions such as headache, dental pain, menstrual cramps, musculoskeletal injuries, and postoperative pain.

  2. Anti-inflammatory Effect: Clonixin lysinate possesses anti-inflammatory properties, making it useful in the management of inflammatory conditions such as arthritis, bursitis, tendonitis, and other musculoskeletal disorders. By inhibiting the production of prostaglandins and other inflammatory mediators, clonixin lysinate helps reduce swelling, redness, and stiffness associated with inflammation, thereby improving symptoms and functional mobility.

  3. Antipyretic Effect: In addition to its analgesic and anti-inflammatory effects, clonixin lysinate has antipyretic properties, meaning it can help reduce fever. By inhibiting the synthesis of prostaglandins in the brain's hypothalamus, clonixin lysinate helps lower body temperature and alleviate fever associated with infectious diseases, inflammatory conditions, or other causes.

  4. Rheumatic Conditions: Clonixin lysinate may be prescribed for the management of rheumatic conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and juvenile idiopathic arthritis. It can help reduce pain, inflammation, and stiffness associated with these conditions, thereby improving joint function and quality of life for affected individuals.

  5. Dosage and Administration: Clonixin lysinate is typically administered orally in the form of tablets or capsules, although intravenous formulations may also be available for certain medical settings. The dosage and frequency of clonixin lysinate therapy depend on factors such as the severity of pain or inflammation, the individual patient's response to treatment, and the specific formulation used. Patients should follow the instructions provided by their healthcare provider or medication label for proper dosing and administration.

  6. Side Effects: Like other NSAIDs, clonixin lysinate may be associated with certain side effects, particularly when used at high doses or for prolonged periods. Common side effects may include gastrointestinal disturbances such as dyspepsia, nausea, vomiting, abdominal pain, and diarrhea. Less common but more serious side effects may include gastrointestinal ulcers or bleeding, cardiovascular events such as heart attack or stroke, renal impairment, allergic reactions, and liver toxicity. Patients should be monitored regularly for signs of adverse effects, especially if they have preexisting medical conditions or risk factors.

  7. Contraindications and Precautions: Clonixin lysinate is contraindicated in individuals with hypersensitivity to NSAIDs or any of their components, as well as in patients with a history of aspirin-induced asthma, peptic ulcer disease, gastrointestinal bleeding, severe renal impairment, or hepatic dysfunction. It should be used with caution in elderly patients, individuals with cardiovascular risk factors, and those taking other medications that may interact with clonixin lysinate.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of clonixin lysinate,(prescription) On Probiotics

Rank Probiotic Impact
genus Bifidobacterium Reduces
species Anaerobutyricum hallii Reduces
species Bacteroides uniformis Reduces
species Bifidobacterium adolescentis Reduces
species Bifidobacterium longum Reduces
species Blautia hansenii Reduces
species Escherichia coli Reduces
species Lacticaseibacillus paracasei Reduces
species Lactococcus cremoris Reduces
species Parabacteroides distasonis Reduces
species Streptococcus thermophilus Reduces
subspecies Bifidobacterium longum subsp. infantis Reduces
subspecies Bifidobacterium longum subsp. longum Reduces

Bacteria Impacted by clonixin lysinate,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

πŸ““ Direct Citations πŸ‘ͺπŸ‘Ά Indirect Citations Taxonomy Rank Effect
0 1 Odoribacter genus Decreases
0 1 Streptococcus genus Decreases
0 1 Dorea genus Decreases
0 1 Segatella genus Decreases
0 1 Escherichia genus Decreases
0 1 Mediterraneibacter genus Decreases
0 1 Parabacteroides genus Decreases
0 1 Ruminococcus genus Decreases
0 1 Bacteroides genus Decreases
0 1 Fusobacterium genus Decreases
0 1 Shigella genus Decreases
0 1 Lacticaseibacillus genus Decreases
0 1 Coprobacter genus Decreases
0 1 Coprococcus genus Decreases
0 1 Bilophila genus Decreases
0 1 Bifidobacterium genus Decreases
0 1 Clostridium genus Decreases
0 1 Roseburia genus Decreases
0 2 Phocaeicola genus Increases
0 1 Escherichia coli O1:K1:H7 no rank Decreases
0 1 Escherichia coli O139:H1 no rank Decreases
0 1 Escherichia coli O141:H4 no rank Decreases
0 1 Escherichia coli O145:H34 no rank Decreases
0 1 Escherichia coli O15:H12 no rank Decreases
0 1 Escherichia coli O155:H21 no rank Decreases
0 1 Escherichia coli O158:H23 no rank Decreases
0 1 Escherichia coli O16:H48 no rank Decreases
0 1 Escherichia coli O170:H18 no rank Decreases
0 1 Escherichia coli O18ac:H14 no rank Decreases
0 1 Escherichia coli O19:H7 no rank Decreases
0 1 Escherichia coli O2:K1:H4 no rank Decreases
0 1 Escherichia coli O2:K1:H5 no rank Decreases
0 1 Escherichia coli O2:K1:H7 no rank Decreases
0 1 Escherichia coli O20:H12 no rank Decreases
0 1 Escherichia coli O25:H16 no rank Decreases
0 1 Escherichia coli O55:H7 no rank Decreases
0 1 Escherichia coli O68:H12 no rank Decreases
0 1 Escherichia coli O7:H15 no rank Decreases
0 1 Escherichia coli O78:H51 no rank Decreases
0 1 Escherichia coli O80:H26 no rank Decreases
0 1 Escherichia coli O84:H7 no rank Decreases
0 1 Escherichia coli O85:H1 no rank Decreases
0 1 Clostridium perfringens A no rank Decreases
0 1 Clostridium perfringens B no rank Decreases
0 1 Clostridium perfringens C no rank Decreases
0 1 Clostridium perfringens CPE no rank Decreases
0 1 Clostridium perfringens D no rank Decreases
0 1 Clostridium perfringens E no rank Decreases
0 1 Escherichia coli O103 serogroup Decreases
0 1 Escherichia coli O111 serogroup Decreases
0 1 Escherichia coli O119 serogroup Decreases
0 1 Escherichia coli O121 serogroup Decreases
0 1 Escherichia coli O145 serogroup Decreases
0 1 Escherichia coli O155 serogroup Decreases
0 1 Escherichia coli O157 serogroup Decreases
0 1 Escherichia coli O177 serogroup Decreases
0 1 Escherichia coli O26 serogroup Decreases
0 1 Escherichia coli O3 serogroup Decreases
0 1 Escherichia coli O43 serogroup Decreases
0 1 Escherichia coli O5 serogroup Decreases
0 1 Escherichia coli O78 serogroup Decreases
0 1 Escherichia coli O86 serogroup Decreases
0 1 Escherichia coli O91 serogroup Decreases
0 1 Escherichia coli H20 serotype Decreases
0 1 Escherichia coli O1:H42 serotype Decreases
0 1 Escherichia coli O1:HNT serotype Decreases
0 1 Escherichia coli O10:H32 serotype Decreases
0 1 Escherichia coli O10:K5(L):H4 serotype Decreases
0 1 Escherichia coli O100:H21 serotype Decreases
0 1 Escherichia coli O103:H11 serotype Decreases
0 1 Escherichia coli O103:H2 serotype Decreases
0 1 Escherichia coli O103:H25 serotype Decreases
0 1 Escherichia coli O104:H21 serotype Decreases
0 1 Escherichia coli O104:H4 serotype Decreases
0 1 Escherichia coli O111:H- serotype Decreases
0 1 Escherichia coli O111:H11 serotype Decreases
0 1 Escherichia coli O111:H8 serotype Decreases
0 1 Escherichia coli O111:NM serotype Decreases
0 1 Escherichia coli O112ab:H8 serotype Decreases
0 1 Escherichia coli O112ac:H19 serotype Decreases
0 1 Escherichia coli O113:H21 serotype Decreases
0 1 Escherichia coli O114:H49 serotype Decreases
0 1 Escherichia coli O118:H16 serotype Decreases
0 1 Escherichia coli O121:H19 serotype Decreases
0 1 Escherichia coli O121:H7 serotype Decreases
0 1 Escherichia coli O123:H11 serotype Decreases
0 1 Escherichia coli O125ac:K+:H10 serotype Decreases
0 1 Escherichia coli O126:H45 serotype Decreases
0 1 Escherichia coli O127:H27 serotype Decreases
0 1 Escherichia coli O127:H6 serotype Decreases
0 1 Escherichia coli O128:H2 serotype Decreases
0 1 Escherichia coli O128ac:H12 serotype Decreases
0 1 Escherichia coli O139:H28 serotype Decreases
0 1 Escherichia coli O145:H25 serotype Decreases
0 1 Escherichia coli O145:H28 serotype Decreases
0 1 Escherichia coli O145:NM serotype Decreases
0 1 Escherichia coli O146:H21 serotype Decreases
0 1 Escherichia coli O15:H18 serotype Decreases
0 1 Escherichia coli O150:H6 serotype Decreases
0 1 Escherichia coli O152:H23 serotype Decreases
0 1 Escherichia coli O153:H2 serotype Decreases
0 1 Escherichia coli O156:H25 serotype Decreases
0 1 Escherichia coli O157:H- serotype Decreases
0 1 Escherichia coli O157:H43 serotype Decreases
0 1 Escherichia coli O157:H7 serotype Decreases
0 1 Escherichia coli O157:NM serotype Decreases
0 1 Escherichia coli O16:H6 serotype Decreases
0 1 Escherichia coli O165:H25 serotype Decreases
0 1 Escherichia coli O167:H26 serotype Decreases
0 1 Escherichia coli O174:H2 serotype Decreases
0 1 Escherichia coli O174:H21 serotype Decreases
0 1 Escherichia coli O174:H8 serotype Decreases
0 1 Escherichia coli O176:H45 serotype Decreases
0 1 Escherichia coli O177:NM serotype Decreases
0 1 Escherichia coli O2:H6 serotype Decreases
0 1 Escherichia coli O2:K2:H1 serotype Decreases
0 1 Escherichia coli O25:H1 serotype Decreases
0 1 Escherichia coli O25:NM serotype Decreases
0 1 Escherichia coli O26:H1 serotype Decreases
0 1 Escherichia coli O26:H11 serotype Decreases
0 1 Escherichia coli O28ac:NM serotype Decreases
0 1 Escherichia coli O29:H4 serotype Decreases
0 1 Escherichia coli O32:H37 serotype Decreases
0 1 Escherichia coli O39:NM serotype Decreases
0 1 Escherichia coli O44:H18 serotype Decreases
0 1 Escherichia coli O45:H2 serotype Decreases
0 1 Escherichia coli O6:H16 serotype Decreases
0 1 Escherichia coli O6:H16:CFA/II serotype Decreases
0 1 Escherichia coli O6:K2:H1 serotype Decreases
0 1 Escherichia coli O69:H11 serotype Decreases
0 1 Escherichia coli O7:H4 serotype Decreases
0 1 Escherichia coli O7:K1 serotype Decreases
0 1 Escherichia coli O78:H12 serotype Decreases
0 1 Escherichia coli O78:H4 serotype Decreases
0 1 Escherichia coli O79:H7 serotype Decreases
0 1 Escherichia coli O8:H8 serotype Decreases
0 1 Escherichia coli O81:NM serotype Decreases
0 1 Escherichia coli O83:H1 serotype Decreases
0 1 Escherichia coli O86:H34 serotype Decreases
0 1 Escherichia coli O89m:H10 serotype Decreases
0 1 Escherichia coli O89m:H9 serotype Decreases
0 1 Escherichia coli O9:H10 serotype Decreases
0 1 Escherichia coli O91:H14 serotype Decreases
0 1 Escherichia coli O91:NM serotype Decreases
0 1 Escherichia coli O99:H6 serotype Decreases
0 1 Escherichia coli ONT:H33 serotype Decreases
1 0 Escherichia coli species Decreases
1 0 Mediterraneibacter gnavus species Decreases
1 0 Bacteroides thetaiotaomicron species Decreases
1 0 Bacteroides uniformis species Decreases
1 0 Dorea formicigenerans species Decreases
1 0 Odoribacter splanchnicus species Decreases
1 0 Parabacteroides merdae species Decreases
1 0 Segatella copri species Decreases
1 0 Streptococcus salivarius species Decreases
1 0 Ruminococcus bromii species Decreases
0 1 Streptococcus sp. FDAARGOS_192 species Decreases
1 0 Fusobacterium nucleatum species Decreases
1 0 Bacteroides caccae species Decreases
1 0 Bacteroides fragilis species Decreases
1 0 Lacticaseibacillus paracasei species Decreases
0 1 Shigella dysenteriae species Decreases
0 1 Shigella flexneri species Decreases
0 1 Escherichia albertii species Decreases
0 1 Escherichia fergusonii species Decreases
1 0 Parabacteroides distasonis species Decreases
0 1 Blautia argi species Decreases
0 1 Shigella boydii species Decreases
0 1 Streptococcus vestibularis species Decreases
0 1 Segatella bryantii species Decreases
0 1 Bacteroides sp. CACC 737 species Decreases
1 0 Bifidobacterium longum species Decreases
0 1 Streptococcus parasanguinis species Decreases
0 1 Streptococcus sp. LPB0220 species Decreases
1 0 Bacteroides xylanisolvens species Decreases
0 1 Streptococcus sp. HSISM1 species Decreases
1 0 Coprococcus comes species Decreases
1 0 Bilophila wadsworthia species Decreases
0 1 Shigella sonnei species Decreases
0 1 Dorea longicatena species Decreases
0 1 Escherichia marmotae species Decreases
0 1 Escherichia sp. E4742 species Decreases
0 1 Blautia obeum species Decreases
0 1 Bacteroides sp. HF-162 species Decreases
0 1 Coprococcus catus species Decreases
0 1 Bacteroides humanifaecis species Decreases
0 1 Leyella stercorea species Decreases
0 1 Streptococcus sp. oral taxon 061 species Decreases
0 1 Alistipes megaguti species Decreases
0 1 Blautia hansenii species Decreases
0 1 Anaerobutyricum hallii species Decreases
0 1 Streptococcus australis species Decreases
0 1 Wansuia hejianensis species Decreases
0 1 Prevotella intermedia species Decreases
0 1 Streptococcus lactarius species Decreases
0 1 Blautia parvula species Decreases
0 1 Streptococcus gordonii species Decreases
0 1 Blautia sp. SC05B48 species Decreases
0 1 Coprobacter fastidiosus species Decreases
1 0 Bifidobacterium adolescentis species Decreases
0 1 Blautia producta species Decreases
0 1 Streptococcus oralis species Decreases
0 1 Leyella lascolaii species Decreases
0 1 Streptococcus sp. Marseille-Q6470 species Decreases
0 1 Thomasclavelia ramosa species Decreases
0 1 Coprobacter secundus species Decreases
0 1 Streptococcus sp. oral taxon 431 species Decreases
0 1 Komagataeibacter oboediens species Decreases
0 1 Ligilactobacillus ruminis species Decreases
0 1 Barnesiella viscericola species Decreases
0 1 [Ruminococcus] torques species Decreases
0 1 Adlercreutzia equolifaciens species Decreases
0 1 Lactococcus cremoris species Decreases
0 1 Eubacterium ventriosum species Decreases
0 1 Subdoligranulum variabile species Decreases
0 1 Enterocloster bolteae species Decreases
0 1 Streptococcus infantis species Decreases
0 1 Anaerostipes caccae species Decreases
0 1 Bacteroides luhongzhouii species Decreases
0 1 Streptococcus suis species Decreases
0 1 Butyricimonas faecalis species Decreases
0 1 Paraprevotella clara species Decreases
0 1 Prevotella bivia species Decreases
0 1 uncultured Alistipes sp. species Decreases
0 1 Mogibacterium diversum species Decreases
0 1 Actinomyces oris species Decreases
0 1 Mageeibacillus indolicus species Decreases
0 1 Butyricimonas virosa species Decreases
0 1 Parabacteroides johnsonii species Decreases
0 1 Streptococcus mutans species Decreases
0 1 Fannyhessea vaginae species Decreases
0 1 Lacrimispora saccharolytica species Decreases
0 1 Bacteroides nordii species Decreases
0 1 Faecalibacillus intestinalis species Decreases
0 1 Actinomyces sp. oral taxon 169 species Decreases
0 1 Alistipes ihumii species Decreases
0 1 Streptococcus ilei species Decreases
0 1 Streptococcus thermophilus species Decreases
0 1 Parvimonas micra species Decreases
0 1 Treponema denticola species Decreases
0 1 Prevotella dentalis species Decreases
0 1 Corynebacterium durum species Decreases
0 1 [Ruminococcus] lactaris species Decreases
1 0 Clostridium perfringens species Decreases
1 0 Roseburia intestinalis species Decreases
2 0 Phocaeicola vulgatus species Increases
0 1 Phocaeicola vulgatus 274-1D4 strain Increases
0 1 Phocaeicola vulgatus ATCC 8482 strain Increases
0 1 Phocaeicola vulgatus CL09T03C04 strain Increases
0 1 Phocaeicola vulgatus dnLKV7 strain Increases
0 1 Phocaeicola vulgatus PC510 strain Increases
0 1 Phocaeicola vulgatus RJ2L3 strain Increases
0 1 Phocaeicola vulgatus str. 3775 SL(B) 10 (iv) strain Increases
0 1 Phocaeicola vulgatus str. 3775 SR(B) 19 strain Increases
0 1 Phocaeicola vulgatus str. 3975 RP4 strain Increases
0 1 Fusobacterium nucleatum subsp. nucleatum subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. tolerans subspecies Decreases
0 1 Bifidobacterium longum subsp. infantis subspecies Decreases
0 1 Bifidobacterium longum subsp. longum subspecies Decreases
0 1 Bifidobacterium longum subsp. suillum subspecies Decreases
0 1 Bifidobacterium longum subsp. suis subspecies Decreases

Impact of clonixin lysinate,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.7 0.7
Acne 0.1 -0.1
ADHD 2.7 0.2 12.5
Age-Related Macular Degeneration and Glaucoma 0.5 0.3 0.67
Allergic Rhinitis (Hay Fever) 2.5 1.7 0.47
Allergies 3.9 2.2 0.77
Allergy to milk products 1.4 1.2 0.17
Alopecia (Hair Loss) 0.8 0.8
Alzheimer's disease 4.6 3.5 0.31
Amyotrophic lateral sclerosis (ALS) Motor Neuron 2 1 1
Ankylosing spondylitis 3.4 1.4 1.43
Anorexia Nervosa 1.1 1.9 -0.73
Antiphospholipid syndrome (APS) 1.7 0.1 16
Asthma 3.9 0.9 3.33
Atherosclerosis 2.4 0.7 2.43
Atrial fibrillation 2.3 1.9 0.21
Autism 5.4 5.7 -0.06
Autoimmune Disease 1.1 0.1 10
Barrett esophagus cancer 0.2 0.4 -1
benign prostatic hyperplasia 0.6 0.3 1
Biofilm 2.5 2.5
Bipolar Disorder 1.5 0.4 2.75
Brain Trauma 0.5 0.7 -0.4
Breast Cancer 1.2 1.2
Cancer (General) 0.6 1.4 -1.33
Carcinoma 3.3 1.7 0.94
Celiac Disease 2.2 2.1 0.05
Cerebral Palsy 0.8 0.6 0.33
Chronic Fatigue Syndrome 4.3 4.7 -0.09
Chronic Kidney Disease 2.9 0.4 6.25
Chronic Lyme 0.3 -0.3
Chronic Obstructive Pulmonary Disease (COPD) 2.5 0.7 2.57
Chronic Urticaria (Hives) 1.5 1 0.5
Coagulation / Micro clot triggering bacteria 2 0.7 1.86
Cognitive Function 1.7 0.9 0.89
Colorectal Cancer 5.9 1.3 3.54
Constipation 1.1 0.1 10
Coronary artery disease 2.7 1.4 0.93
COVID-19 7 8.1 -0.16
Crohn's Disease 6.7 2.7 1.48
Cushing's Syndrome (hypercortisolism) 0.1 0.3 -2
cystic fibrosis 1 0.5 1
d-lactic acidosis (one form of brain fog) 0.7 0.7
deep vein thrombosis 2.3 1 1.3
Denture Wearers Oral Shifts 1.7 1.7
Depression 6.7 4.2 0.6
Dermatomyositis 0.4 0.1 3
Eczema 1.9 1.7 0.12
Endometriosis 2.9 1.5 0.93
Eosinophilic Esophagitis 0.2 0.4 -1
Epilepsy 2.7 1.3 1.08
erectile dysfunction 1.1 0.1 10
Fibromyalgia 1.5 1.8 -0.2
Functional constipation / chronic idiopathic constipation 3.8 2.9 0.31
gallstone disease (gsd) 3.1 0.3 9.33
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 1.2 0.8 0.5
Generalized anxiety disorder 2.9 1.1 1.64
giant cell arteritis 0 0
Glioblastoma 0.4 -0.4
Gout 1.6 0.3 4.33
Graves' disease 0.9 1.4 -0.56
Gulf War Syndrome 0.5 1.1 -1.2
Halitosis 1.4 0.4 2.5
Hashimoto's thyroiditis 2 0.6 2.33
Heart Failure 3.7 0.5 6.4
hemorrhagic stroke 0.9 0.9
Hidradenitis Suppurativa 1 1
High Histamine/low DAO 0.8 0.4 1
hypercholesterolemia (High Cholesterol) 1.1 1.1
hyperglycemia 2 0.7 1.86
Hyperlipidemia (High Blood Fats) 0.2 0.2
hypersomnia 0.1 -0.1
hypertension (High Blood Pressure 3 3.2 -0.07
Hypothyroidism 0.1 0.2 -1
Hypoxia 1.1 1.1
IgA nephropathy (IgAN) 1.6 2.8 -0.75
Inflammatory Bowel Disease 5.4 5.6 -0.04
Insomnia 1.9 1.1 0.73
Intelligence 1.8 0.6 2
Intracranial aneurysms 1.2 0.1 11
Irritable Bowel Syndrome 4.8 2.3 1.09
ischemic stroke 2.3 0.9 1.56
Liver Cirrhosis 4.7 2.7 0.74
Long COVID 4.5 4.1 0.1
Low bone mineral density 0.2 -0.2
Lung Cancer 1.1 0.8 0.38
Lymphoma 0.6 0.1 5
Mast Cell Issues / mastitis 1.4 0.5 1.8
ME/CFS with IBS 0.7 1.8 -1.57
ME/CFS without IBS 1.2 1.8 -0.5
membranous nephropathy 0.4 0.4
Menopause 0.9 0 0
Metabolic Syndrome 5.7 4.2 0.36
Mood Disorders 6 3.4 0.76
multiple chemical sensitivity [MCS] 1.1 1.1
Multiple Sclerosis 3.6 3.6 0
Multiple system atrophy (MSA) 0.2 0.4 -1
myasthenia gravis 1 0 0
neuropathic pain 1.3 -1.3
Neuropathy (all types) 0.4 1.3 -2.25
neuropsychiatric disorders (PANDAS, PANS) 1.5 1.5
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 4.1 1.7 1.41
NonCeliac Gluten Sensitivity 0.4 0.4 0
Obesity 7 5.6 0.25
obsessive-compulsive disorder 4 3.1 0.29
Osteoarthritis 2.6 1.2 1.17
Osteoporosis 1.2 1.1 0.09
pancreatic cancer 1.3 0.4 2.25
Parkinson's Disease 5.5 3.5 0.57
Polycystic ovary syndrome 5 2.2 1.27
Postural orthostatic tachycardia syndrome 0 0.3 0
Premenstrual dysphoric disorder 0.1 0.3 -2
primary biliary cholangitis 0.8 1.3 -0.63
Primary sclerosing cholangitis 1.5 1.9 -0.27
Psoriasis 2.5 1.6 0.56
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 5.7 2 1.85
Rosacea 0.5 0 0
Schizophrenia 3.6 1.1 2.27
scoliosis 0.9 0.4 1.25
sensorineural hearing loss 0.3 0.3
Sjögren syndrome 2.3 1.8 0.28
Sleep Apnea 1.4 0.4 2.5
Slow gastric motility / Gastroparesis 1.2 0.1 11
Small Intestinal Bacterial Overgrowth (SIBO) 1.7 0.2 7.5
Stress / posttraumatic stress disorder 2.2 0.8 1.75
Systemic Lupus Erythematosus 3.5 1 2.5
Tic Disorder 1.1 1.4 -0.27
Tourette syndrome 0.8 0.3 1.67
Type 1 Diabetes 2.3 1.7 0.35
Type 2 Diabetes 5.6 4.9 0.14
Ulcerative colitis 4.2 4.3 -0.02
Unhealthy Ageing 3.3 1 2.3
Vitiligo 1.8 0.7 1.57

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]